Menu
Recruiting NCT07048418

Aesthetic and Functional Self-Assessment Following Rhinoseptoplasty in Patients With Unilateral Cleft Lip and Palate

Observational Cleft Lip and Cleft Palate

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Mailing and completing CLEFT-Q and NOSE questionnaires.
Who it may be relevant to
Registry conditions: Cleft Lip and Cleft Palate. Basic parameters: 18 years — 30 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Secondary rhino-septoplasty in unilateral cleft lip and palate is the treatment of choice for the correction of aesthetic deformities and the functional impact on ventilation nasal. It remains a difficult treatment. It can be proposed at the end of growth or from the age of 10, depending on nasal obstruction and the severity of the deformity. The CLEFT-Q questionnaire, validated in 2017, has not yet been widely used in studies. The NOSE questionnaire is an older functional questionnaire that is complementary to the CLEFT-Q. Cleft lip and palate are rare diseases, accounting for around 30% of all facial clefts, which occur at a rate of 1/750 births in Europe. Deformation of the nose and nasal septum is constant, and more or less severe in unilateral forms. In the absence of rhino-septoplasty performed during primary cleft repair surgery, deformities persist in children and adolescents. There is a significant aesthetic impact in children, which generally increases in adolescents. The problem of nasal obstruction causes functional discomfort that can be disabling. Open rhino-septoplasty is a standard procedure and is proposed as a secondary treatment in this population . It is indicated during growth in cases of nasal obstruction, or as a function of aesthetic demands. The hypothesis is that secondary rhino-septoplasty gives long-term satisfaction in patients in terms of aesthetics and respiratory function. The originality of this study lies in the use of the recently validated CLEFT-Q questionnaire to assess the aesthetic and functional satisfaction of patients in adulthood after secondary rhino-septoplasty performed in childhood or adolescence. This long-term follow-up will enable us to assess the stability of aesthetic and functional results.

Interventions

  • Other Mailing and completing CLEFT-Q and NOSE questionnaires
    Mailing and completing CLEFT-Q and NOSE questionnaires

Primary outcome measures

  • Nasal Obstruction and Septoplasty Effectiveness (NOSE) Scale [Time frame: At inclusion (i.e. 3 to 20 years after surgery, according to inclusion criteria)]
  • CLEFT-Q nose appearance [Time frame: At inclusion (i.e. 3 to 20 years after surgery, according to inclusion criteria)]
  • CLEFT-Q nostrils appearance [Time frame: At inclusion (i.e. 3 to 20 years after surgery, according to inclusion criteria)]
  • CLEFT-Q face appearance [Time frame: At inclusion (i.e. 3 to 20 years after surgery, according to inclusion criteria)]
Secondary outcome measures (2)
  • Asher Mc Dade Score [Time frame: At least 6 months after surgery]
  • Surgical complications according to the Clavien Dindo classification [Time frame: few days after surgery]

Eligibility criteria

Inclusion criteria

Unilateral cleft lip and palate Surgery performed at the university hospital as primary surgery (before 12 months of age) without rhino-septoplasty Rhino-septoplasty performed at the university hospital as secondary surgery in childhood or adolescence Aged between 18 and 30 years at the time the CLEFT Q questionnaire was sent out.

Exclusion criteria

Incomplete clinical file Primary operation elsewhere than at the Montpellier University Hospital Other operation on the nose prior to rhinoseptoplasty Subject unable to read and/or write Impossibility of following the patient during the study period Opposition to participation after a period of reflection Non affiliation to a social security scheme Persons subject to a legal protection measure (placed under safeguard of justice, persons under guardianship or curatorship), Persons participating in another research study including an exclusion period still in progress Pregnant or breast-feeding women

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

France · 1 center
  • CHU Montpellier — Montpellier

Identifiers

NCT: NCT07048418 · RECHMPL25_0017

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗